FTC sues big pharmacy reward professionals more than insulin prices The company introduced action against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the record cost of life-conserving insulin prescription drugs. Insurers will proceed vertically integrating to help keep far more earnings in-house, https://daveshotchickennutrition16161.ttblogs.com/10215873/the-5-second-trick-for-healthcare-news